Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 20: 1213-1216, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warnock, L. G.
Right arrow Articles by Wagner, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warnock, L. G.
Right arrow Articles by Wagner, C.

Clinical Chemistry, Vol 20, 1213-1216, Copyright © 1974 by the American Association for Clinical Chemistry

Decreased Aspartate Aminotransferase ("SGOT") Activity in Serum of Uremic Patients

Laken G. Warnock 1, William J. Stone 1, and Conrad Wagner 1

1 Research and Nephrology Divisions, Veterans Administration Hospital, Nashville, Tenn. 37203; and the Department of Biochemistry, Vanderbilt University, Nashville, Tenn. 37232.

Aspartate aminotransferase activity in the serum of uremic patients and of normal individuals was analyzed by three different methods: (a) a manual ultraviolet method, (b) a manual colorimetric method, and (c) by continuous flow (SMA 12/60 AutoAnalyzer; Technicon). Both dialyzed and undialyzed uremic patients exhibit low values for serum aspartate aminotransferase activity, regardless of the method used. The SMA 12/60 procedure exaggerates this decrease because of ultraviolet-absorbing materials in uremic serum. The activity of this enzyme did not exceed normal values in one uremic patient after a myocardial infarction and recurrent severe cardiac episodes. Such results suggest that this procedure should be used with great care as an index for diagnosing myocardial infarctions (and perhaps hepatitis) in uremic patients.


Key Words: AutoAnalyzer • inter-method comparison • diagnostic aid • myocardial infarction • hepatitis

Submitted on May 31, 1974
Accepted on July 3, 1974




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
P. Rosenthal
Assessing liver function and hyperbilirubinemia in the newborn
Clin. Chem., January 1, 1997; 43(1): 228 - 234.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
B. S. CHANG, R. V. BARNES, and F. K. PORT
Transaminase Levels in Azotemia
Ann Intern Med, August 1, 1976; 85(2): 255 - 256.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
G. A. COHEN, J. A. GOFFINET, R. K. DONABEDIAN, and H. O. CONN
Observations on Decreased Serum Glutamic Oxalacetic Transaminase (SGOT) Activity in Azotemic Patients
Ann Intern Med, March 1, 1976; 84(3): 275 - 280.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.